Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure

BACKGROUND: Whereas selective sodium-glucose cotransporter 2 (SGLT2) inhibitors consistently showed cardiovascular protective effects in large outcome trials independent of the presence of type 2 diabetes mellitus (T2DM), the cardiovascular effects of dual SGLT1/2 inhibitors remain to be elucidated....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Sayour, Alex Ali, Oláh, Attila, Ruppert, Mihály, Barta, Bálint András, Horváth, Eszter Mária, Benke, Kálmán, Pólos, Miklós, Hartyánszky, István, Merkely, Béla, Radovits, Tamás
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7528261/
https://ncbi.nlm.nih.gov/pubmed/32998746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01141-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars